Novo faces shareholder suit over insulin sales disclosures

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 16, 2019 at 1:02 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,730
    Likes Received:
    3
    via Shareholders in Novo Nordisk accused the diabetes drugmaker of misleading investors about its insulin drug sales in the U.S., filing a securities lawsuit in Danish court that demands roughly $1.75 billion.

    article source